Analysis of the titer and reactivity of antibody/ies against fungal cell wall β-glucans in human sera

International Journal of Medicinal Mushrooms

Volumn 15, Issue 2, 2013, Pages 115-126

  Ishibashi, Ken Ichi ^a   Morita, Mayu ^a   Motoi, Masuro ^a   Liu, Ying ^b   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

glucan; Anti glucan antibody; Class; Medicinal mushrooms and fungi; Reactivity

Indexed keywords

BETA GLUCAN; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE;

ADULT; AGARICUS; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CANDIDA ALBICANS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL CELL WALL; GRIFOLA FRONDOSA; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE;

ADULT; ANTIBODIES; ANTIBODY SPECIFICITY; ASPERGILLUS; BETA-GLUCANS; CELL WALL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; YOUNG ADULT;

BASIDIOMYCOTA; CANDIDA; FUNGI;

EID: 84875479936     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v15.i2.10     Document Type: Article

References (36)

1. Kollar R, Reinhold BB, Petrakova E, Yeh HJ, Ashwell G, Drgonova J, Kapteyn JC, Klis FM, Cabib E. Architecture of the yeast cell wall. Beta (1→6)-glucan interconnects mannoprotein, beta(1→)3-glucan, and chitin. J Biol Chem. 1997;272:17762-75.
2. Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev. 1998;62:130-80.
3. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345:17-20.
4. Czop JK, Austen KF. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis. Proc Natl Acad Sci U S A. 1985;82:2751-55.
5. Hoffman OA, Standing JE, Limper AH. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J Immunol. 1993;150:3932-40.
6. Ohno N, Uchiyama M, Tsuzuki A, Tokunaka K, Miura NN, Adachi Y, Aizawa MW, Tamura H, Tanaka S, Yadomae T. Solubilization of yeast cell-wall beta-(1→3)-Dglucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr Res. 1999;316:161-72.
7. Ishibashi K, Miura NN, Adachi Y, Tamura H, Tanaka S, Ohno N. The solubilization and biological activities of Aspergillus beta-(1→3)-D-glucan. FEMS Immunol Med Microbiol. 2004;42:155-66.
8. Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. Antitumor beta glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull. 2001;24:820-28.
9. Ohno N, Iino K, Takeyama T, Suzuki I, Sato K, Oikawa S, Miyazaki T, Yadomae T. Structural characterization and antitumor activity of the extracts from matted mycelium of cultured Grifola frondosa. Chem Pharm Bull. 1985;33:2564-68.
10. Ohno N, Yadomae T. Structure-activity relationship of immunomodulating (1→3)-β-D-glucans. Recent Res Devel Chem Pharm Sci. 1996;1:23-33.
11. Yadomae T. Structure and biological activities of fungal beta-1,3-glucans. Yakugaku Zasshi. 2000;120:413-31.
12. Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ. Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement. 1987;4:61-74.
13. Zimmerman JW, Lindermuth J, Fish PA, Palace GP, Stevenson TT, DeMong DE. A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem. 1998;273:22014-20.
14. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 2001;413:36-37.
15. Masuzawa S, Yoshida M, Ishibsahi K, Saito N, Akashi M, Yoshikawa N, Suzuki T, Nameda S, Miura NN, Adachi Y, Ohno N. Solubilized Candida cell wall β-glucan, CSBG, is epitope of natural human antibody. Drug Develop Res. 2003;58:179-89.
16. Ishibashi K, Yoshida M, Nakabayashi I, Shinohara H, Miura NN, Adachi Y, Ohno N. Role of anti-beta-glucan antibody in host defense against fungi. FEMS Immunol Med Microbiol. 2005;44:99-109.
17. Uchiyama M, Ohno N, Miura NN, Adachi Y, Aizawa MW, Tamura H, Tanaka S, Yadomae T. Chemical and immunochemical characterization of limulus factor Gactivating substance of Candida spp. FEMS Immunol Med Microbiol. 1999;24:411-20.
18. Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun. 1986;51:668-74.
19. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol. 1999;2:363-67.
20. Casadevall A, Feldmesser M, Pirofski LA. Induced humoral immunity and vaccination against major human fungal pathogens. Curr Opin Microbiol. 2002;5:386-91.
21. Xin H, Dziadek S, Bundle DR, Cutler JE. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A. 2008;105:13526-31.
22. Devi SJ. Preclinical efficacy of a glucuronoxylomannantetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine model. Vaccine. 1996;14:841-44.
23. Pachl J, Svoboda P, Jacobs F, Vandewoude K, van der Hoven B, Spronk P, Masterson G, Malbrain M, Aoun M, Garbino J, Takala J, Drgona L, Burnie J, Matthews R; Mycograb Invasive Candidiasis Study Group. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibodybased inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis. 2006;42:1404-13.
24. Mukherjee J, Scharff MD, Casadevall A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun. 1992;60:4534-41.
25. Harada T, Nagi Miura N, Adachi Y, Nakajima M, Yadomae T, Ohno N. Antibody to soluble 1,3/1,6-beta-D-glu-can, SCG in sera of naive DBA/2 mice. Biol Pharm Bull. 2003;26:1225-28.
26. Ishibashi K, Dogasaki C, Iriki T, Motoi M, Kurone Y, Miura NN, Adachi Y, Ohno N. Anti-β-glucan antibody in bovine sera. Int J Med Mushr. 2005;7:533-45.
27. Yoshida M, Ishibashi K, Hida S, Yoshikawa N, Nakabayashi I, Akashi M, Watanabe T, Tomiyasu T, Ohno N. Rapid decrease of anti-beta-glucan antibody as an indicator for early diagnosis of carinii pneumonitis and deep mycotic infections following immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis. Clin Rheumatol. 2009;28:565-71.
28. Farmaki E, Evdoridou J, Pouliou T, Bibashi E, Panagopoulou P, Filioti J, Benos A, Sofianou D, Kremenopoulos G, Roilides E. Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections. Am J Perinatol. 2007;24:127-35.
29. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662-65.
30. Keller RG, Pfrommer GS, Kozel TR. Occurrences, specificities, and functions of ubiquitous antibodies in human serum those are reactive with the Cryptococcus neoformans cell wall. Infect Immun. 1994;62:215-20.
31. Ueda Y, Liao D, Yang K, Patel A, Kelsoe G. T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J Immunol. 2007;178:3593-3601.
32. Bredius RG, de Vries CE, Troelstra A, van Alphen L, Weening RS, van de Winkel JG, Out TA. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol. 1993;151:1463-72.
33. Sato T, Iwabuchi K, Nagaoka I, Adachi Y, Ohno N, Tamura H, Seyama K, Fukuchi Y, Nakayama H, Yoshizaki F, Takamori K, Ogawa H. Induction of human neutrophil chemotaxis by Candida albicans-derived beta-1,6-long glycoside side-chain-branched beta-glucan. J Leukoc Biol. 2006;80:204-11.
34. Adams EL, Rice PJ, Graves B, Ensley HE, Yu H, Brown GD, Gordon S, Monteiro MA, Papp-Szabo E, Lowman DW, Power TD, Wempe MF, Williams DL. Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching. J Pharmacol Exp Ther. 2008;325:115-23.
35. Thornton BP, V̌tvicka V, Pitman M, Goldman RC, Ross GD. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol. 1996;156:1235-46.
36. Huang ZY, Hunter S, Chien P, Kim MK, Han-Kim TH, Indik ZK, Schreiber AD. Interaction of two phagocytic host defense systems: Fcγ receptors and complement receptor 3. J Biol Chem. 2011;286:160-68.